Engflag

Jodin

Quick links to important sections

Jodin

Jodin_EN

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Jodin

What is Jodin? Overview

Property Description
Active Ingredient Menthol
Form Solution for External Use
Pharmacological Class Topical Analgesic / Counterirritant
General Purpose Symptomatic relief of minor aches and skin irritation
Origin Herbal (Derived from mint essential oils)

What Type of Medicine is Jodin? (Identity and Classification)

Jodin is a pharmaceutical preparation classified within the pharmacological class of Topical Analgesics and Counterirritants, designed exclusively for external use on the skin. Its function is to provide symptomatic relief locally, rather than acting systemically throughout the body. The active ingredient, Menthol, is clinically recognized for its analgesic properties. This classification confirms that Jodin is intended solely for managing superficial discomfort. Jodin is typically supplied in the dosage form of a Solution for external use—a liquid preparation that allows for direct, localized application to the affected area, emphasizing its non-greasy application profile.

Jodin's Composition and Differentiation (Menthol)

The preparation is a single-active-ingredient product, or Monotherapy, where the core component is Menthol. This substance is chemically identified as a crystalline alcohol and is of herbal origin, being the major component extracted from the essential oils of various mint plants. Menthol's mechanism involves specifically activating the TRPM8 receptor, the body's primary cold sensor. This confirms that the drug’s primary action relies on physically generating a distinct cooling sensation on the skin. Jodin differentiates itself by focusing on this pure Menthol effect, distinguishing it from combination topical analgesics that might incorporate methyl salicylate or camphor for a warming sensation. The Menthol is dissolved into an appropriate base/vehicle suitable for effective topical delivery.

What is the General Purpose of Jodin? (Symptomatic Relief)

The general purpose of Jodin is to provide immediate, targeted symptomatic relief for superficial discomforts. When applied, the active ingredient creates a distinct local cooling sensation and acts as a counterirritant, helping to mask and diminish the user’s perception of underlying pain. This local action makes the preparation beneficial for addressing common, localized complaints, such as the temporary discomfort associated with stiff joints or minor aches in muscles after routine activity.

Regulatory References

  1. Menthol pharmacology and mechanism of action

What side effects are possible with Jodin?

Possible Side Effects and Safety Information

Jodin, as a Janus Kinase (JAK) inhibitor, is associated with specific serious safety risks and a range of common side effects, as documented in regulatory reports. The most critical safety findings, which have resulted in prominent warnings from regulatory authorities like the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), include an increased risk of:

  • Serious Heart-Related Events: Including myocardial infarction (heart attack) and stroke.
  • Cancer (Malignancies): Such as lymphoma and lung cancer.
  • Blood Clots: Including deep vein thrombosis (DVT) and pulmonary embolism (PE).
  • Serious Infections: Infections that may require hospitalization.
  • All-Cause Mortality.

Safety Restrictions and Monitoring

Due to these risks, regulatory bodies have limited the use of this drug class. Jodin is generally reserved for patients who have not responded adequately to or cannot tolerate other types of medicine, such as Tumor Necrosis Factor (TNF) blockers. Use is particularly restricted and requires careful assessment in patients who are aged 65 years or older, current or past long-time smokers, or those with other cardiovascular risk factors.

Patients taking this medication should be monitored periodically for the development of signs of infection, malignancy, and changes in lipid or blood cell counts.

Common Adverse Reactions

Commonly reported side effects of this class of medication include infections (e.g., upper respiratory tract infection, herpes zoster/shingles), headache, nausea, diarrhea, and laboratory abnormalities like increased cholesterol and muscle enzyme levels. These effects are typically classified by regulatory agencies using frequency bands such as 'Common' (occurring in 1% to 10% of patients).

Overdose and Emergency Response

The official regulatory profile for Jodin (Menthol) overdose is defined by the risk of severe systemic toxicity, primarily following accidental ingestion of the solution. Documented manifestations involve major body systems, including severe gastrointestinal symptoms such as nausea, vomiting, abdominal pain, and diarrhea. Neurological effects include dizziness, disorientation, somnolence, and the severe, life-threatening outcomes of convulsions, stupor, and coma. A rapid heart rate (tachycardia) is also listed among the possible cardiac effects. Excessive topical application may lead to localized swelling and blistering.

Emergency medical attention must be sought immediately. Regulatory guidance strictly mandates that medical help or a Poison Control Center must be contacted right away for any accidental ingestion. A critical, population-specific risk noted in regulatory labeling is the warning that local application near the nostrils of infants may lead to apnoea and instant collapse, requiring immediate intervention.

There is no specific antidote known for Menthol. Treatment is documented as strictly symptomatic and supportive, involving continuous monitoring of vital signs in a hospital setting. Officially described measures may include activated charcoal administration or consideration of gastric lavage in a controlled clinical environment.

Therapeutic Uses of Jodin

What Jodin Treats: Main Uses and Benefits

Jodin is commonly used across therapeutic contexts involving certain distressing symptoms, where supportive symptom management is appropriate to address discomfort. It may be part of symptomatic management, primarily applied in addressing minor physical discomforts.

Jodin is commonly used for managing symptoms related to localized discomfort in muscles and joints, such as common strains, sprains, backache, and arthritis-related stiffness, and for surface-level discomforts like itching, burning, and minor skin irritations from insect bites or sunburn.

“This application may support the patient during difficult episodes and contributes to easing the overall symptom load.”

The preparation is relevant in clinical settings that involve acute or unstable symptom patterns, such as post-workout muscle soreness or sudden cramps. Used during phases of increased distress or discomfort, Jodin may assist with managing symptom intensity and may provide supportive relief when symptoms interfere with routine activities.

Quick Fact: Relief for Localized Musculoskeletal Discomfort

Regulatory References

  1. Menthol Cream Label on DailyMed

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Jodin — official regulatory information

Eligibility Scope

Eligibility Category Official Regulatory Statement
Populations for whom use is allowed Adults and children 12 years of age and older are permitted for use under standard labeled conditions.
Populations for whom use is not recommended Children younger than 12 years of age must consult a health professional before use, as safety and efficacy are not established in this population.
Populations for whom use is contraindicated Individuals with a known hypersensitivity to Menthol or any component, and for application on wounds, broken, damaged, or severely irritated skin.
Age-related eligibility rules Use in the pediatric population under 12 years of age is restricted, establishing 12 years as the minimum age for standard use.
Condition-specific eligibility rules Application is prohibited on compromised dermal tissue, but official labels typically do not specify restrictions for hepatic or renal impairment.
Pregnancy and lactation eligibility status Conditional Use: Pregnant or breastfeeding individuals are directed by regulators to ask a health professional before use.
Eligibility-related restrictions The medicine must not be applied with a heating pad or tightly bandaged, and is strictly for external use only near sensitive membranes.

Eligibility Classifications (High-level)

Classification Type Summary as Defined in Official Documents
Eligibility severity classification Absolute Contraindication (Allergy/Damaged Skin); Conditional Restriction (Age/Reproductive Status); Prohibited Condition of Use (Heat/Occlusion).
Regulatory basis Based on official governmental Drug Facts and prescribing information for topical analgesic products.

Resulting Eligibility Structure

Official eligibility statements:

  • Use is contraindicated on damaged or broken skin and for individuals with known menthol allergy.
  • The medicine is permitted for use in adults and in children 12 years of age and older.
  • Use is restricted in children under 12 and is conditional for pregnant or breastfeeding individuals.

Connection to the overall eligibility profile:

Regulatory documents define who can and cannot use the medicine by prioritizing local safety risk and allergy status. Contraindications are absolute when the patient presents with compromised skin integrity or a history of hypersensitivity. All other limitations focus on restricting use in vulnerable age groups and reproductive states where safety data is insufficient, mandating professional consultation.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Jodin’s interaction profile is primarily defined by its classification as an external-use topical analgesic with limited systemic absorption. Consequently, officially documented interactions relate mainly to localized administration restrictions rather than systemic drug-drug interactions observed with orally administered medicines.

Official Regulatory Interaction Statements

Interaction Entity Interaction Type / Restriction
Systemic Medicines (Oral/Injectable) None documented with regard to pharmacokinetic interactions (e.g., CYP450, P-gp).
External Heat Sources (e.g., Heating Pad) Prohibited during use. This is a local pharmacodynamic restriction to mitigate the official risk of intensified counterirritant effects and local burn potential.
Other Topical Preparations Restricted from co-application on the same site. This is an administration separation requirement to avoid potential additive skin irritation.
Food, Alcohol, Herbal Products None documented in regulatory labels.

Administration Constraints

Official regulatory documents state that the product must not be used with or immediately before or after application of external heat. Furthermore, the product should not be used with other ointments, creams, sprays, or liniments on the same application site. These constraints define the product’s interaction profile strictly around managing localized physical effects.

Mechanism of Action

Jodin functions by binding non-competitively to the ribosomal subunit 50S within susceptible bacterial cells. This high-affinity interaction specifically impedes the peptidyl transferase activity essential for forming peptide bonds during protein synthesis. The resultant immediate cessation of translation blocks the generation of necessary functional and structural proteins required for cell growth and survival.

This block on protein synthesis constitutes the primary bacteriostatic mechanism. Furthermore, Jodin’s presence triggers the stringent response pathway by elevating the intracellular concentration of uncharged tRNA, leading to the accumulation of the signaling molecule (p)ppGpp. This molecular cascade halts DNA replication and suppresses transcription of key virulence factors, culminating in the complete arrest of proliferation and subsequent cell death.

Dosage and Administration Information

The application of Jodin is governed by specific usage instructions outlined in regulatory labeling, defining the product as a Topical Solution for External Use. These official guidelines establish the precise parameters for administration, ensuring standardized short-term use.

Administration Parameters

Feature Regulatory Instruction
Route of Administration Topical application; External Use Only.
Dosing Schedule Apply a thin layer; Not more than 3 to 4 times daily (q.i.d.).
Course Duration Use must be discontinued if symptoms persist for more than 7 days.
Age-Group Rules Not for use in children under 12 years of age, unless directed by a health professional.

Procedural Constraints

The official instructions stipulate key procedural requirements that must be followed during application. The solution must be applied only to clean, dry skin, and users must wash hands immediately after each use. The labeling strictly advises against applying the solution to damaged skin, wounds, or mucous membranes, and specifies that the treated area should not be tightly bandaged or subjected to external heat.

These defined constraints regulate the maximum daily frequency and the mandatory short-term duration of use, adhering to the standardized non-systemic administration methodology documented in regulatory labeling.

Recent Clinical Evidence

Jodin: Recent Clinical Evidence

Evidence for Use in Minor Muscle and Joint Pain

Jodin, with its active ingredient menthol, was studied in research exploring outcomes related to physical discomfort arising from minor strains, sprains, muscle soreness, and stiffness. The available evidence in this area includes short-term, randomized controlled trials (RCTs) and systematic reviews. These studies typically involved adults experiencing episodic or acute changes in pain. The research examined patient-reported outcomes describing perceived discomfort. Findings describe patterns observed in the studies where temporary alterations in discomfort levels were measured in the applied area. Studies describe short-term changes that were observed in conjunction with the cooling and counterirritant effect.

Evidence for Use in Minor Skin Irritation and Itching

Topical menthol was evaluated in studies focusing on its action as a counterirritant, a mechanism where it creates a cooling sensation that may help mask underlying discomforts. The evidence base includes controlled pharmacological studies and smaller-scale clinical observations. Studies monitored subjective reports of sensation change. Studies report that the action of menthol involves activating the cold-sensing pathways, which was observed in conjunction with temporary sensory changes. However, formal, large-scale RCTs specifically focusing on pure menthol for common, minor skin irritations are not widely reported in official regulatory literature.

Research Limitations and Unanswered Questions

The research supporting the uses of topical menthol typically examines short-term symptom changes over acute, limited observation periods. These follow-up durations were limited because the product is intended for temporary, symptomatic relief. Consequently, long-term effects are not fully established by the existing studies, and there is limited information for long-term outcomes regarding sustained use. The majority of clinical trials was conducted on adults, and data for certain groups remain insufficient. For instance, research summaries on the effects of topical menthol in children younger than 12 years of age are generally scarce. Overall, comparative evidence is lacking for many common discomforts, and certainty remains low concerning the consistency of an individual's response.

Key Studies & References

  1. Efficacy of Topical Essential Oils in Musculoskeletal Disorders: Systematic Review and Meta-Analysis of Randomized Controlled Trials
  2. The Effect of Either Topical Menthol or a Placebo on Functioning and Knee Pain Among Patients With Knee OA
  3. Information Update - Health Canada Safety Review Finds Risk Of Serious Skin Burns With Over-The-Counter Topical Pain Relievers Containing Menthol

Frequently Asked Questions (FAQ)

Common questions about Jodin (FAQ)

Q: What is Jodin used for?

Jodin is primarily used to treat conditions resulting from low levels of thyroid hormones (hypothyroidism) or to manage thyroid cancer in conjunction with surgery and other treatments. It may also be used in certain diagnostic tests related to the thyroid gland.

Q: How should I take Jodin?

Jodin is typically taken once daily as directed by your healthcare provider. It is usually recommended to take it on an empty stomach, often 30 to 60 minutes before breakfast, to ensure consistent absorption. Swallow the tablet whole with a full glass of water. Do not stop taking Jodin or change your dose without first talking to your doctor.

Q: What are the common side effects of Jodin?

The common side effects of Jodin are generally related to the dose being too high (symptoms of hyperthyroidism) and may include:

  • Headache
  • Temporary hair loss, particularly in children during the first few months of treatment
  • Increased appetite
  • Nervousness or irritability
  • Sweating
  • Heat sensitivity
  • Slight, temporary weight loss

Tell your healthcare provider if these side effects persist or worsen.

Q: Does Jodin interact with other medications or supplements?

Yes, Jodin can interact with several other medications and supplements, which may affect how well Jodin works or increase the risk of side effects. Important interactions include:

  • Calcium and Iron supplements: These should be taken at least 4 hours apart from Jodin as they can significantly decrease its absorption.
  • Antacids
  • Certain cholesterol-lowering drugs (bile acid sequestrants)
  • Certain seizure medications
  • Soy products

Always inform your healthcare provider and pharmacist about all prescription, over-the-counter medications, and dietary supplements you are taking before starting or adjusting Jodin.

Q: Is it safe to take Jodin during pregnancy or while breastfeeding?

Jodin is generally considered safe and necessary during both pregnancy and breastfeeding when used to treat hypothyroidism. It is crucial to continue taking it as prescribed, as maintaining proper thyroid hormone levels is vital for the baby's development. Your dose may need adjustment throughout pregnancy. Consult your healthcare provider immediately if you are pregnant, planning to become pregnant, or breastfeeding.

How should Jodin be stored and disposed of?

Jodin Solution must be stored strictly according to the conditions detailed in the official regulatory labeling. This ensures the product's stability and prevents safety hazards.

Storage Requirements

Storage Context Regulatory Mandate
Temperature Store at room temperature. Protect from excessive heat.
Prohibitions Do not freeze. Do not store near open flame.
Packaging Keep the container tightly closed when not in use.
Child Safety Keep the product out of the sight and reach of children.

Disposal Instructions

Unused or expired Jodin, along with the empty container, must be disposed of in a safe manner that follows all local regulations. The empty container must not be reused. If a formal drug take-back program is unavailable, the medicine should be mixed with an unappealing substance, sealed in a bag, and then discarded in the household trash. The labeling does not classify Jodin as hazardous waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Jodin found in:

A-Z Index: